Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application

Masamichi Kobayashi, Michihiko Sone, Masayuki Umemura, Toshitaka Nabeshima, Tsutomu Nakashima, Sten Hellström

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Conclusion. Among the three main gentamicin (GM) compounds following intratympanic application, the cochleotoxicity of C2 was the most severe, whereas that of C1a was the weakest. Understanding of the different cochleotoxicity characteristics of each compound may be of use in future custom-made intratympanic therapy for Ménière's disease. Objective. To investigate differences in cochleotoxicity among three major GM compounds following intratympanic application. Materials and methods. Three GM compounds (C1, C2, and C1a) were isolated. Sprague-Dawley rats were treated every 2 days for 2 weeks with intratympanic application of saline, GM complex, C1, C2, and C1a. The cochleotoxicity of each compound was assessed by measuring auditory brainstem response (ABR) and through morphological analyses using scanning electron microscopy. Results. The ABR threshold of the C2 group was found to be more impaired than those of the other groups. The C1a group showed the mildest elevation of the ABR thresholds. Morphological analyses revealed that the proportion of remaining outer hair cells (OHCs) was the lowest in animals treated with C2. Morphologically, the C1 and C1a groups showed the least damage to OHCs.

Original languageEnglish
Pages (from-to)245-249
Number of pages5
JournalActa Oto-Laryngologica
Volume128
Issue number3
DOIs
Publication statusPublished - 22-02-2008
Externally publishedYes

Fingerprint

Gentamicins
Outer Auditory Hair Cells
Brain Stem Auditory Evoked Potentials
Electron Scanning Microscopy
Sprague Dawley Rats
gentamicin C
Therapeutics

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Kobayashi, Masamichi ; Sone, Michihiko ; Umemura, Masayuki ; Nabeshima, Toshitaka ; Nakashima, Tsutomu ; Hellström, Sten. / Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application. In: Acta Oto-Laryngologica. 2008 ; Vol. 128, No. 3. pp. 245-249.
@article{7fba3d933733480495460178fcb4a06d,
title = "Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application",
abstract = "Conclusion. Among the three main gentamicin (GM) compounds following intratympanic application, the cochleotoxicity of C2 was the most severe, whereas that of C1a was the weakest. Understanding of the different cochleotoxicity characteristics of each compound may be of use in future custom-made intratympanic therapy for M{\'e}ni{\`e}re's disease. Objective. To investigate differences in cochleotoxicity among three major GM compounds following intratympanic application. Materials and methods. Three GM compounds (C1, C2, and C1a) were isolated. Sprague-Dawley rats were treated every 2 days for 2 weeks with intratympanic application of saline, GM complex, C1, C2, and C1a. The cochleotoxicity of each compound was assessed by measuring auditory brainstem response (ABR) and through morphological analyses using scanning electron microscopy. Results. The ABR threshold of the C2 group was found to be more impaired than those of the other groups. The C1a group showed the mildest elevation of the ABR thresholds. Morphological analyses revealed that the proportion of remaining outer hair cells (OHCs) was the lowest in animals treated with C2. Morphologically, the C1 and C1a groups showed the least damage to OHCs.",
author = "Masamichi Kobayashi and Michihiko Sone and Masayuki Umemura and Toshitaka Nabeshima and Tsutomu Nakashima and Sten Hellstr{\"o}m",
year = "2008",
month = "2",
day = "22",
doi = "10.1080/00016480701558948",
language = "English",
volume = "128",
pages = "245--249",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "3",

}

Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application. / Kobayashi, Masamichi; Sone, Michihiko; Umemura, Masayuki; Nabeshima, Toshitaka; Nakashima, Tsutomu; Hellström, Sten.

In: Acta Oto-Laryngologica, Vol. 128, No. 3, 22.02.2008, p. 245-249.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparisons of cochleotoxicity among three gentamicin compounds following intratympanic application

AU - Kobayashi, Masamichi

AU - Sone, Michihiko

AU - Umemura, Masayuki

AU - Nabeshima, Toshitaka

AU - Nakashima, Tsutomu

AU - Hellström, Sten

PY - 2008/2/22

Y1 - 2008/2/22

N2 - Conclusion. Among the three main gentamicin (GM) compounds following intratympanic application, the cochleotoxicity of C2 was the most severe, whereas that of C1a was the weakest. Understanding of the different cochleotoxicity characteristics of each compound may be of use in future custom-made intratympanic therapy for Ménière's disease. Objective. To investigate differences in cochleotoxicity among three major GM compounds following intratympanic application. Materials and methods. Three GM compounds (C1, C2, and C1a) were isolated. Sprague-Dawley rats were treated every 2 days for 2 weeks with intratympanic application of saline, GM complex, C1, C2, and C1a. The cochleotoxicity of each compound was assessed by measuring auditory brainstem response (ABR) and through morphological analyses using scanning electron microscopy. Results. The ABR threshold of the C2 group was found to be more impaired than those of the other groups. The C1a group showed the mildest elevation of the ABR thresholds. Morphological analyses revealed that the proportion of remaining outer hair cells (OHCs) was the lowest in animals treated with C2. Morphologically, the C1 and C1a groups showed the least damage to OHCs.

AB - Conclusion. Among the three main gentamicin (GM) compounds following intratympanic application, the cochleotoxicity of C2 was the most severe, whereas that of C1a was the weakest. Understanding of the different cochleotoxicity characteristics of each compound may be of use in future custom-made intratympanic therapy for Ménière's disease. Objective. To investigate differences in cochleotoxicity among three major GM compounds following intratympanic application. Materials and methods. Three GM compounds (C1, C2, and C1a) were isolated. Sprague-Dawley rats were treated every 2 days for 2 weeks with intratympanic application of saline, GM complex, C1, C2, and C1a. The cochleotoxicity of each compound was assessed by measuring auditory brainstem response (ABR) and through morphological analyses using scanning electron microscopy. Results. The ABR threshold of the C2 group was found to be more impaired than those of the other groups. The C1a group showed the mildest elevation of the ABR thresholds. Morphological analyses revealed that the proportion of remaining outer hair cells (OHCs) was the lowest in animals treated with C2. Morphologically, the C1 and C1a groups showed the least damage to OHCs.

UR - http://www.scopus.com/inward/record.url?scp=39349095080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39349095080&partnerID=8YFLogxK

U2 - 10.1080/00016480701558948

DO - 10.1080/00016480701558948

M3 - Article

VL - 128

SP - 245

EP - 249

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 3

ER -